Petros Pharmaceuticals, Inc. Notes Payable, Noncurrent
Petros Pharmaceuticals, Inc. (PTPI) had Notes Payable, Noncurrent of $4.92 million as of 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermNotesPayable · last filed 2025-03-31
- 2024-09-30: Notes Payable, Noncurrent $4.92M.
- 2024-06-30: Notes Payable, Noncurrent $5.70M.
- 2024-03-31: Notes Payable, Noncurrent $6.46M.
- 2023-12-31: Notes Payable, Noncurrent $6.86M.
| Period end | Notes Payable, Noncurrent |
|---|---|
| 2024-09-30 | $4.92M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $5.70M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $6.46M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $6.86M 10-K · filed 2025-03-31 |
| 2023-09-30 | $7.25M 10-Q · filed 2023-11-15 |
| 2023-06-30 | $7.63M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $8.01M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $8.39M 10-K · filed 2024-04-01 |
| 2022-09-30 | $8.76M 10-Q/A · filed 2022-11-15 |
| 2022-06-30 | $9.12M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $9.48M 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |